Current strategies for identifying and validating targets for new treatment-shortening drugs for TB

KJ Williams; K Duncan

doi:10.2174/156652407780598575

Back

Current strategies for identifying and validating targets for new treatment-shortening drugs for TB

Journal article

Peer reviewed

Current strategies for identifying and validating targets for new treatment-shortening drugs for TB

KJ Williams and K Duncan

CURRENT MOLECULAR MEDICINE, Vol.7(3), pp.297-307

01/05/2007

DOI: https://doi.org/10.2174/156652407780598575

Abstract

Science & Technology

Life Sciences & Biomedicine

Medicine

Research & Experimental

Research & Experimental Medicine

MEDICINE

RESEARCH & EXPERIMENTAL

tuberculosis

drug discovery

essential gene

target validation

MYCOBACTERIUM-TUBERCULOSIS H37RV

STRUCTURAL GENOMICS CONSORTIUM

GENE-EXPRESSION PROFILES

IN-VITRO

MDR-TB

NITROIMIDAZOPYRAN PA-824

CRYSTALLIZATION FACILITY

TRANSPOSON MUTAGENESIS

PULMONARY TUBERCULOSIS

CONDITIONAL EXPRESSION

Files and links (1)

url

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000246677700006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View

Author

Metrics

33 Record Views

33 Times Cited - Web of Science

See more details

Details

Title: Current strategies for identifying and validating targets for new treatment-shortening drugs for TB
Creators: KJ Williams
K Duncan
Publication Details: CURRENT MOLECULAR MEDICINE, Vol.7(3), pp.297-307
Publisher: BENTHAM SCIENCE PUBL LTD
Date published: 01/05/2007
Date submitted: 17/05/2017
Identifiers: 99512663002346
Academic Unit: University of Surrey
Language: English
Resource Type: Journal article

Current strategies for identifying and validating targets for new treatment-shortening drugs for TB

Abstract

Files and links (1)

Metrics

Details

Usage Policy